A Study to Evaluate Zilebesiran in Japanese Patients With Mild to Moderate Hypertension
Status:
COMPLETED
Trial end date:
2025-07-17
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability, efficacy, pharmacodynamics (PD) and pharmacokinetics (PK) of zilebesiran in Japanese patients with mild to moderate hypertension.